Resistant Wastewater

Researchers find an antibiotic resistance gene in wastewater treatment plants in northern China.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wastewater treatment plant in ChinaYI LUO, NANKAI UNIVERSITYMany genes can cause antibiotic resistance in bacteria, but New Delhi metallo-beta-lactamase 1 (NDM-1) is especially dangerous because it allows microbes to destroy beta-lactam antibiotics, which are typically one of the last lines of defense against drug-resistant infections. Now, researchers have found NDM-1 in wastewater and sludge from two treatment plants in China. Their work was published in Environmental Science & Technology Letters earlier this month (December 4).

Researchers from Rice University in Houston, Texas, and from Nankai and Tianjin Universities in China sampled wastewater and sludge that had been treated by chlorination in wastewater treatment plants in northern China. They performed PCR on the samples and showed that NDM-1 was present—the water contained more than 1,000 gene copies per milliliter and sludge contained 40 million to 60 million copies per mL. The scientists also isolated a bacterial strain carrying NDM-1 that was resistant to the eight antibiotics that they tested. They showed that NDM-1 could be transferred between bacteria in river sludge that was previously negative for the gene, suggesting that more bacteria may become resistant as wastewater is released into the environment.

“It turns out that [the bacteria] transfer these genetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies